Furthermore, the knockdown of MMP-13 at the tumor-bone interface by treatment with MMP-13 antisense oligonucleotide significantly reduced bone destruction, indicating that MMP-13 contributes to breast cancer-induced osteolysis (89). Here, MMP13 is linked to breast cancer.